May 10, 2018

Financing Supports Development of Vesper Medical's Venous Stents

May 11, 2018—Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that it has completed its Series A financing totaling $10.5 million. Vesper Medical plans to use the proceeds from this financing to complete the development of its Vesper Duo venous stent system inclusive of the in vivo testing necessary to obtain the approvals required for clinical testing of the Vesper Duo stents.

Privately held Vesper Medical is a spinout of Intact Vascular, Inc. Major participants in the Series A financing included New Enterprise Associates and Quaker Partners. The financing occurred in two tranches and is now complete, advised the company.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

May 10, 2018

Financing Supports Development of Vesper Medical's Venous Stents

Current Issue

Keep In Touch